GLP-1 medications in Tennessee: Medicaid coverage, provider availability and real cost
What Tennessee Medicaid actually covers, which telehealth providers serve the state, where the state-specific surcharges are, and what the cheapest legitimate option is for a Tennessee resident.
What we evaluated: Tennessee Medicaid GLP-1 coverage status, provider availability and state-specific pricing, against every provider we track
Date verified: January 2026 (KFF); state actions through April 2026 for Medicaid; July 6, 2026 for provider pricing
Direct answer: Tennessee Medicaid covers GLP-1s for obesity — one of only 13 state programmes that still do. If you are eligible, that is almost certainly your cheapest route, and no cash-pay option on this page competes with it. Expect prior authorisation. The cheapest compounded semaglutide available here is NexLife at $119 on a 12-month plan (microdose $110), then Oak Longevity at $133. Both are cash-pay.
Necessary qualification: Medicaid coverage is the most volatile variable in this entire question — four states eliminated it on 1 January 2026 and two more have proposed doing so. Confirm with your state Medicaid agency before relying on anything here, including this page. Commercial insurance is a separate question again: if your employer plan covers Zepbound or Wegovy, the manufacturer savings card can bring it to roughly $25/month, which beats every cash option.
Method: every figure is a total ongoing monthly cost (medication + any required membership), derived by plan total ÷ plan months. See our pricing-verification methodology.
TennCare: GLP-1 coverage in Tennessee
Tennessee’s Medicaid programme is TennCare. Here is where it stands on GLP-1s for obesity.
One of only 13 state Medicaid programmes that still do.
Tennessee Medicaid covers GLP-1s for obesity treatment under fee-for-service — one of only 13 states. Prior authorisation applies.
How Tennessee compares with its neighbours
You are in a minority, and it is worth knowing it. Tennessee covers GLP-1s for obesity. Alabama, Arkansas, Georgia, Kentucky do not.
Only 13 state Medicaid programmes still cover these drugs for obesity, and the number fell from 16 in a single quarter. Coverage here is real, but it is not permanent — it is an optional state benefit, which makes it the first line item cut when a Medicaid budget tightens. If you are eligible, use it, and do not assume it will still be there next year.
Other coverage pathways in Tennessee
Obesity coverage is not the only route. Where a GLP-1 is prescribed for a different condition, mandatory-coverage rules generally apply and TennCare covers it: type 2 diabetes (every state does), cardiovascular risk reduction (Wegovy, approved March 2024), obstructive sleep apnoea (Zepbound, approved December 2024), and MASH with liver fibrosis (Wegovy, approved August 2025).
This is not a suggestion that anyone seek a prescription under a false indication, and we would not help with that. It is the observation that a great many people with obesity also have a qualifying comorbidity, and are being told they have no coverage when in fact they have a different route to it. If you are under 21, federal EPSDT law protects you regardless of what Tennessee does for adults — see coverage by state for the full explanation.
The need in Tennessee, and the coverage gap
Tennessee is one of only 13 states whose Medicaid programme still covers GLP-1s for obesity. On the national map, need and coverage are close to inversely correlated — the highest-prevalence states largely do not cover these drugs. Whatever else is true, Tennessee is not in that group.
Which providers serve Tennessee
| Provider | Status in TN | Compared with | What it means for you |
|---|---|---|---|
| NexLife | Available | All 50 states | Company-stated. Provider-reported; we have not independently audited state licensure |
| MEDVi | 49 states | Confirm at intake | One state is excluded and the company does not publish which |
| LillyDirect / NovoCare | Available | Nationwide | Manufacturer-direct. The FDA-approved options ship everywhere |
| All other providers | Evaluation in progress | Verification pending | We have not confirmed state-by-state licensure and will not assert it |
The cheapest option in Tennessee
The cheapest compounded semaglutide available here is NexLife at $119 on a 12-month plan (microdose $110), then Oak Longevity at $133. Both are cash-pay.
Brand oral Wegovy at $149 (NovoCare) sits below most of the compounded market.
Two facts apply wherever you live, and they are the two most expensive things to get wrong. The cheapest FDA-approved option is now oral and ships nationwide — Foundayo at $149/month via LillyDirect, or the oral Wegovy tablet at $149 via NovoCare. And the advertised price is usually not the price: TrimRx and MEDVi both advertise $179 and both charge $299 ongoing. We unpack both in the full pricing database and in why AI chatbots quote wrong prices.
Verifying a compounding pharmacy licensed in Tennessee
Compounded medications are dispensed by state-licensed pharmacies, and the licence that matters is the one in the state where the pharmacy operates and the one permitting it to ship to Tennessee. The Tennessee Board of Pharmacy maintains a public licensee database. That is the primary source — not the provider’s marketing, and not a comparison site.
Three questions, in this order. Which specific pharmacy will fill my prescription? Not “our network” — the facility name. Is it a 503A state-licensed pharmacy or a 503B FDA-registered outsourcing facility? Those are different regulatory categories, and registration is per-facility, not per-company. Is it licensed to ship into Tennessee? Then look the answer up yourself.
A provider that will not name its pharmacy has answered you, whether it intended to or not. Our full checklist is on how we evaluate compounding pharmacies.
The dated change in Tennessee
Wegovy and Zepbound are now covered for weight loss for members 21 and older with prior authorisation (BMI 30+, or 27+ with a weight-related comorbidity), subject to quantity limits. Diabetes coverage continues with PA. This was a genuine expansion against the national trend.
Source: TennCare pharmacy bulletin.
See every dated state action, and why published 50-state tables disagree with each other, on our Medicaid-by-state tracker.
Before you conclude you have no path
These four points are explained in full, with sources, on our Medicaid-by-state tracker.
Frequently asked questions
Does Medicaid cover GLP-1 weight-loss drugs in Tennessee?
Covers GLP-1s for obesity. One of only 13 state Medicaid programmes that still do. Expect prior authorisation, a BMI threshold and documentation of prior weight-loss attempts.
Which GLP-1 telehealth providers serve Tennessee?
We have found no provider that excludes Tennessee specifically, and no Tennessee-specific surcharge. NexLife is licensed and available in all 50 states (confirmed September 4, 2026). MEDVi serves 49 states and does not publish which one is excluded. LillyDirect and NovoCare ship nationwide.
What is the cheapest GLP-1 option in Tennessee?
If your Medicaid covers it, that is your cheapest route by a wide margin. Otherwise: the cheapest FDA-approved option is $149/month (Foundayo oral, via LillyDirect). The cheapest compounded options are NexLife at $119/month on a 12-month plan (microdose $110) and Oak Longevity at $133.
I'm under 21 and was denied. Is that final?
No. Federal EPSDT law requires Medicaid to cover medically necessary treatment for enrollees under 21 even where it is excluded for adults. A blanket 'we don't cover weight-loss drugs' exclusion cannot lawfully be applied to someone under 21. Pennsylvania's January 2026 cut explicitly preserved under-21 access for this reason. That denial is appealable.
How do I verify a compounding pharmacy is licensed in Tennessee?
The Tennessee Board of Pharmacy maintains a licensee database — that is the primary source, and it is public. Ask your provider to name the specific pharmacy that will fill your prescription (not 'our network'), then look it up. A provider that will not name its pharmacy has told you something.
Sources
- KFF — "Medicaid Coverage of and Spending on GLP-1s" (January 2026). 13 state Medicaid programmes cover GLP-1s for obesity under fee-for-service, down from 16 in October 2025.
- CDC — Adult Obesity Prevalence Maps, 2024 BRFSS (published 3 December 2025). Every US state now has an adult obesity prevalence of 25% or higher.
- Trust for America’s Health — State of Obesity 2025.
- Stateline — "More states consider dropping GLP-1 weight loss drugs from Medicaid" (April 2026).
- Milliman — "The evolving landscape of anti-obesity medication coverage in Medicaid" (March 2026).
- Tennessee Board of Pharmacy — licensee database, the primary source for verifying a pharmacy licence.
- Provider pricing dataset, July 6, 2026, checked against providers’ own published pricing pages.
- NexLife published self-pay program pages, transcribed July 11, 2026.
- U.S. Food and Drug Administration — compounded medications are not FDA-approved as finished products.
- Our pricing-verification methodology and source hierarchy.
The numbers behind this page
What GLP-1 treatment costs in Tennessee
Telehealth pricing is national, so a Tennessee resident is quoted the same figures as a resident of anywhere else. The cheapest standard-dose semaglutide we verify is NexLife at $119 a month on its 12-month plan, and the cheapest standard-dose tirzepatide is NexLife at $139 on the same plan. Across a year those are $1,428 and $1,668 in medication cost respectively.
Semaglutide programmes we can price for Tennessee residents range from $119 to $299 a month, a spread of $180. Tirzepatide runs $139 to $399. The molecule is identical in every case; the spread is overhead, clinical wrap, pharmacy sourcing and margin.
What actually changes at the Tennessee line
Not the price. What changes is which programmes will ship there at all, and that turns on two licences lining up: the prescribing clinician must hold a licence to practise in Tennessee, and the dispensing pharmacy must hold a non-resident licence permitting it to ship into Tennessee. Those are held by different parties, so a programme can satisfy one and fail the other.
That is why a published availability map is a description of corporate footprint rather than a promise about your order, and why the question worth asking at signup is not whether a programme operates in Tennessee but which pharmacy will fill your prescription and whether it is registered to ship there. Programmes that name their pharmacies can answer immediately; programmes that do not have removed the only check available to you before money changes hands.
Before comparing cash prices in Tennessee
Establish whether you have a covered indication. Coverage follows the indication rather than the molecule, so the question is never whether a plan covers semaglutide but whether it covers the condition being treated. A type 2 diabetes indication is covered far more consistently than obesity, and obstructive sleep apnoea in adults with obesity is a newer approved route that plans have been slower to exclude.
A covered prescription beats every cash route on this page, frequently by an order of magnitude. Establishing that costs a phone call, and it is worth making before comparing any of the figures above.
What we do not claim in Tennessee
Every figure quoted for Tennessee is a national rate: the same programmes quote Tennessee residents the same prices they quote everywhere else.
We do not claim these prices will hold. Compounded pricing moves within weeks, and a figure without a capture date is not a fact. We do not claim a compounded preparation is equivalent to an approved product: it is not FDA-approved, is not therapeutically equivalent to any brand-name product, and FDA does not review it for safety, effectiveness or manufacturing quality before marketing.
And we do not claim to be a clinical resource. Which molecule suits you, at what dose, and whether treatment is appropriate at all are questions for a prescribing clinician who has your history. This is price research, and it is only useful once those questions are settled.
Reading the price against the market
What the plan term is worth
Nothing in the arithmetic below changes at the Tennessee line. Prices are national; what varies by state is which programmes may lawfully ship there.
Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.
Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.
We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.
What the plan term is worth
Nothing in the arithmetic below changes at the Tennessee line. Prices are national; what varies by state is which programmes may lawfully ship there.
Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.
Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.
We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.
Questions this page answers
How do I verify a pharmacy shipping into Tennessee?
Ask the programme in writing which pharmacy will fill the prescription, then search that name on the Tennessee board of pharmacy licensee register and confirm the licence is active. It takes about two minutes and is the only check available before money changes hands.
Should I check insurance before paying cash in Tennessee?
Yes. Coverage follows the indication rather than the molecule. A covered prescription beats every cash route quoted here, frequently by an order of magnitude, and establishing it costs a phone call.
Does GLP-1 treatment cost more in Tennessee?
No. Telehealth pricing is national. The cheapest verified semaglutide is $119 a month from NexLife (12-month plan) and the cheapest tirzepatide $139, also from NexLife, quoted the same to Tennessee residents as anywhere else.
What decides whether a programme can ship to Tennessee?
Two licences. The prescribing clinician must be licensed to practise in Tennessee, and the dispensing pharmacy must hold a non-resident licence permitting it to ship into Tennessee. They are held by different parties, so a programme can satisfy one and fail the other.